Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.
Standard
Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries. / Reimer, Jens; Schulte, Bernd; Castells, Xavier; Schäfer, Ingo; Polywka, Susanne; Hedrich, Dagmar; Wiessing, Lucas; Haasen, Christian; Backmund, Markus; Krausz, Michael.
in: CLIN INFECT DIS, Jahrgang 40, Nr. 5, 5, 2005, S. 373-378.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.
AU - Reimer, Jens
AU - Schulte, Bernd
AU - Castells, Xavier
AU - Schäfer, Ingo
AU - Polywka, Susanne
AU - Hedrich, Dagmar
AU - Wiessing, Lucas
AU - Haasen, Christian
AU - Backmund, Markus
AU - Krausz, Michael
PY - 2005
Y1 - 2005
N2 - Treatment guidelines are considered to be an important tool in steering patients to medical treatment. This study was conducted to analyze guidelines for the treatment of hepatitis C virus (HCV) infection in injection drug users (IDUs) in the European Union (EU) countries as a component of treatment access. National and international databases, expert contacts, professional societies, and health administrations were approached to acquire guidelines. According to their quality standard, guidelines were divided into expert opinions, semiofficial guidelines, official guidelines, and consensus processes. Recommendations for the treatment of HCV infection in IDUs vary substantially, from lack of recommendations and outright treatment disapproval to recommendations for treatment under specified circumstances. Recent guidelines that apply qualified process procedures that include literature research tend to be more permissive. Qualified guideline processes in each EU country and subsequently renewed pan-European guidelines are needed.
AB - Treatment guidelines are considered to be an important tool in steering patients to medical treatment. This study was conducted to analyze guidelines for the treatment of hepatitis C virus (HCV) infection in injection drug users (IDUs) in the European Union (EU) countries as a component of treatment access. National and international databases, expert contacts, professional societies, and health administrations were approached to acquire guidelines. According to their quality standard, guidelines were divided into expert opinions, semiofficial guidelines, official guidelines, and consensus processes. Recommendations for the treatment of HCV infection in IDUs vary substantially, from lack of recommendations and outright treatment disapproval to recommendations for treatment under specified circumstances. Recent guidelines that apply qualified process procedures that include literature research tend to be more permissive. Qualified guideline processes in each EU country and subsequently renewed pan-European guidelines are needed.
M3 - SCORING: Zeitschriftenaufsatz
VL - 40
SP - 373
EP - 378
JO - CLIN INFECT DIS
JF - CLIN INFECT DIS
SN - 1058-4838
IS - 5
M1 - 5
ER -